Pilot phase II study of safety and immunogenicity of an ALVAC-CEA/B7.1 vaccine administered with chemotherapy, alone or in combination with tetanus toxoid, as compared to chemotherapy alone, in patients with metastatic colorectal adenocarcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tetanus toxoid (Primary) ; ALVAC CEA; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 06 Jan 2014 Biomarkers information updated
- 04 Nov 2005 New trial record.